Glucagon-like peptide-1 receptor (GLP-1) agonists, widely used to treat obesity and diabetes, may also improve key outcomes for patients with Crohns disease, according to a large real-world study presented during the 2026 Crohns & Colitis Congress, a partnership of AGA and the Crohn's & Colitis Foundation, taking place in Las Vegas
It delivers the strongest balance of protection, runtime, and regulatory readiness without over-engineering
Read More Draft for Comments || Guidelines on the Classification of Deficiencies Observed During Inspection of the Conduct of Clinical Trials 2 July 2026 All comments and feedback may be submitted via email to [[email protected]]
In a controlled trial, young, healthy men were orally administered 300 mg of Withania somnifera root extract twice daily for a duration of eight weeks
Hair loss medically referred to as telogen effluvium when associated with physiological stress or rapid weight change has not been formally listed as a confirmed adverse effect of retatrutide in published trial data
Statements Author contributions JT: writing - review and editing, writing - original draft, supervision, conceptualization, and resources
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
